Endocrine News talks to Sarat Chandarlapaty, MD, PhD, about his research on genetic mutations and breast cancer, his methods, and what impact it might have on the field of endocrinology. Estrogen-disrupting therapies such as fulvestrant and tamoxifen have achieved great success in treating breast cancer. Such drugs, which block the estrogen receptor and inhibit the...
